Screenin3D microfluidic technology is a game-changing approach for pre-clinical drug and therapy testing. At the Festival of Biologics in Basel, Dr Zagnoni presented a talk on our bespoke Onco-Chip^3D technology used for the screening of combination immunotherapies with CAR-Ts and their off-target cytotoxicity.

ScreenIn3D has been awarded the prestigious ELRIG Prize for Innovation in Drug Discovery at their flagship conference Drug Discovery 2019 which recently took place in Liverpool, UK.

(more…)

The MipTec exhibition at the recent Basel Life conference is a platform to get informed about the latest Life Sciences technologies and services for those active in the field of industry relevant, translational, basic and applied research and development.

(more…)

Goodbye Flat Biology brings together researchers who are interested in the techniques and applications of 3D culture at the cancer biology, engineering and drug development interface.

Theresa Mulholland, of ScreenIn3D, attended the event to present a poster – Microfluidic technology for oncology precision medicine.

(more…)